TRP – Morgans rates the stock as Speculative Buy
Morgans initiates coverage on Tissue Repair with a Speculative Buy rating and $1.43 target price.
Read More
Tissue Repair Ltd
Tissue Repair is a clinical stage biopharmaceutical company developing advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures, with the potential for further development of related technologies.
ASX Code
TRP
Sector
Pharmaceuticals- Biotechnology & Life Sciences
Website
https://tissuerepair.com.au/
Videos
Videos coming soon for Tissue Repair Ltd.
All Tissue Repair Ltd Content
